N Mohan

Summary

Country: USA

Publications

  1. ncbi Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents
    Niveditha Mohan
    Avera Research Institute, Sioux Falls, South Dakota 57105, USA
    J Rheumatol 31:1955-8. 2004
  2. ncbi Spectrum of giant cell vasculitis
    N Mohan
    Department of Rheumatology, Veterans Affairs Medical Center, 50 Irving Street, Washington DC 20422, USA
    Curr Rheumatol Rep 2:390-5. 2000
  3. ncbi Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides
    N Mohan
    Georgetown University Medical Center, Washington, DC 20007, USA
    Arthritis Rheum 44:2862-9. 2001
  4. doi ANCA-associated small vessel vasculitis: clinical and therapeutic advances
    Niveditha Mohan
    University of Pittsburgh, Arthritis and Autoimmunity Center, Pittsburgh, PA 15213, USA
    Curr Rheumatol Rep 12:406-13. 2010

Detail Information

Publications4

  1. ncbi Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents
    Niveditha Mohan
    Avera Research Institute, Sioux Falls, South Dakota 57105, USA
    J Rheumatol 31:1955-8. 2004
    ..To describe the clinical features of leukocytoclastic vasculitis (LCV) associated with the use of tumor necrosis factor-alpha (TNF-alpha) blockers...
  2. ncbi Spectrum of giant cell vasculitis
    N Mohan
    Department of Rheumatology, Veterans Affairs Medical Center, 50 Irving Street, Washington DC 20422, USA
    Curr Rheumatol Rep 2:390-5. 2000
    ..The concept of the involved artery as an active participant in the events leading to luminal obstruction has been realized and provides the opportunity to evaluate novel therapies to modify the course of the disease...
  3. ncbi Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides
    N Mohan
    Georgetown University Medical Center, Washington, DC 20007, USA
    Arthritis Rheum 44:2862-9. 2001
    ..To review the occurrence of neurologic events suggestive of demyelination during anti-tumor necrosis factor alpha (anti-TNFalpha) therapy for inflammatory arthritides...
  4. doi ANCA-associated small vessel vasculitis: clinical and therapeutic advances
    Niveditha Mohan
    University of Pittsburgh, Arthritis and Autoimmunity Center, Pittsburgh, PA 15213, USA
    Curr Rheumatol Rep 12:406-13. 2010
    ..However, challenges remain in limiting disease flares and therapy-associated morbidities, and cures are achieved only in cases in which a clear culprit exists...